
Ana Lucrecia Woodward
Examiner (ID: 7465, Phone: (571)272-1082 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1796, 1501, 1711, 1765, 1512, 1314, 1504 |
| Total Applications | 3148 |
| Issued Applications | 2104 |
| Pending Applications | 173 |
| Abandoned Applications | 906 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6818296
[patent_doc_number] => 20030069254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'New arylsulfonyl derivatives with 5-HT6 receptor affinity'
[patent_app_type] => new
[patent_app_number] => 10/215769
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7879
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215769 | Arylsulfonyl derivatives with 5-HT6 receptor affinity | Aug 8, 2002 | Issued |
| 10/214744 | PROCESS FOR PREPARING (S) AND (R)-2-[4-(4-CHLOROBENZHYDRYL)PIPERAZIN-1-YL]-ETHOXYACETAMIDE | Aug 8, 2002 | Abandoned |
Array
(
[id] => 6870647
[patent_doc_number] => 20030083337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists '
[patent_app_type] => new
[patent_app_number] => 10/215910
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11573
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083337.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215910 | Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists | Aug 8, 2002 | Abandoned |
Array
(
[id] => 7362288
[patent_doc_number] => 20040014762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Pyrrolopyridazine compounds'
[patent_app_type] => new
[patent_app_number] => 10/215246
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27584
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215246
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215246 | Pyrrolopyridazine compounds | Aug 7, 2002 | Issued |
Array
(
[id] => 6725598
[patent_doc_number] => 20030207910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/214982
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73030
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10214982
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/214982 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | Aug 6, 2002 | Abandoned |
| 10/111878 | NOVEL COMPOUNDS | Jul 31, 2002 | Abandoned |
Array
(
[id] => 6774696
[patent_doc_number] => 20030018034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Piperazine compounds and medicinal use thereof'
[patent_app_type] => new
[patent_app_number] => 10/209228
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68730
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018034.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209228
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209228 | Piperazine compounds and medicinal use thereof | Jul 31, 2002 | Abandoned |
Array
(
[id] => 1326593
[patent_doc_number] => 06603002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-05
[patent_title] => 'Process and intermediates for growth hormone secretagogues'
[patent_app_type] => B2
[patent_app_number] => 10/209834
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10130
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/603/06603002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209834
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209834 | Process and intermediates for growth hormone secretagogues | Jul 30, 2002 | Issued |
Array
(
[id] => 6792755
[patent_doc_number] => 20030088099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia'
[patent_app_type] => new
[patent_app_number] => 10/207473
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11136
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20030088099.pdf
[firstpage_image] =>[orig_patent_app_number] => 10207473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/207473 | Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia | Jul 28, 2002 | Issued |
Array
(
[id] => 6736247
[patent_doc_number] => 20030013882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Sulfate salt of quinolonecarboxylic acid derivatives and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/182445
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1572
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182445
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182445 | Sulfate salt of quinolonecarboxylic acid derivatives and the use thereof | Jul 28, 2002 | Issued |
Array
(
[id] => 6825780
[patent_doc_number] => 20030236402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Pyrazinones, compositions containing such compounds and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/202817
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14597
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202817 | Pyrazinones, compositions containing such compounds and methods of use | Jul 24, 2002 | Issued |
Array
(
[id] => 6818463
[patent_doc_number] => 20030069421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => '3-(Piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/201593
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31225
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069421.pdf
[firstpage_image] =>[orig_patent_app_number] => 10201593
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/201593 | 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors | Jul 23, 2002 | Issued |
Array
(
[id] => 6721373
[patent_doc_number] => 20030055063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'R-6-hydroxy-buspirone'
[patent_app_type] => new
[patent_app_number] => 10/200931
[patent_app_country] => US
[patent_app_date] => 2002-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4392
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055063.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200931 | R-6-hydroxy-buspirone | Jul 21, 2002 | Issued |
Array
(
[id] => 1096402
[patent_doc_number] => 06821975
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'Beta-carboline drug products'
[patent_app_type] => B1
[patent_app_number] => 10/031463
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6555
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/821/06821975.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031463 | Beta-carboline drug products | Jul 18, 2002 | Issued |
Array
(
[id] => 1240160
[patent_doc_number] => 06686360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-03
[patent_title] => 'N-benzylpiperazine compounds'
[patent_app_type] => B2
[patent_app_number] => 10/195948
[patent_app_country] => US
[patent_app_date] => 2002-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6788
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10195948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/195948 | N-benzylpiperazine compounds | Jul 15, 2002 | Issued |
Array
(
[id] => 645458
[patent_doc_number] => 07119086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 10/484370
[patent_app_country] => US
[patent_app_date] => 2002-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38662
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/119/07119086.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484370
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484370 | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | Jul 14, 2002 | Issued |
Array
(
[id] => 6697339
[patent_doc_number] => 20030109533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'New benzenesulphonamide compounds'
[patent_app_type] => new
[patent_app_number] => 10/195031
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4752
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10195031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/195031 | Benzenesulphonamide compounds | Jul 11, 2002 | Issued |
Array
(
[id] => 990796
[patent_doc_number] => 06919323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-19
[patent_title] => 'Pyridazinone inhibitors of fatty acid binding protein and method'
[patent_app_type] => utility
[patent_app_number] => 10/194028
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11987
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194028
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194028 | Pyridazinone inhibitors of fatty acid binding protein and method | Jul 11, 2002 | Issued |
Array
(
[id] => 1399995
[patent_doc_number] => 06541633
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Bis-(ortho-aminophenol)-carboxylic acid AB2 monomer'
[patent_app_type] => B1
[patent_app_number] => 10/192040
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3175
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192040 | Bis-(ortho-aminophenol)-carboxylic acid AB2 monomer | Jul 9, 2002 | Issued |
Array
(
[id] => 7410710
[patent_doc_number] => 20040176389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Piperazine oxime dervatives having nk-1 receptor antagonistic activity'
[patent_app_type] => new
[patent_app_number] => 10/480542
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9250
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480542
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480542 | Piperazine oxime dervatives having NK-1 receptor antagonistic activity | Jul 2, 2002 | Issued |